尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Wilbur James. Insider active across 1 company, notably 10x Genomics, Inc.. In total, 6 filings have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €1.1m. Activity tracked since 14 September 2022. The latest transaction was filed on 22 November 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Wilbur James is a declarant linked to 10x Genomics, Inc., where he is Chief Commercial Officer. He has 6 filings in total, and across the 6 recent filings covered, they relate to sales between 2022-09-16 and 2023-11-27, with total sales of EUR 1130997 and no purchases indicated.